Infect Chemother.  2006 Feb;38(1):39-44.

A Preliminary Report on the Clinical Efficacy of Telithromycin for the Treatment of Scrub Typhus

Affiliations
  • 1Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea. ljinsoo@inha.ac.kr
  • 2Department of Clinical Microbiology, Inha University College of Medicine, Incheon, Korea.
  • 3Department of Occupational Medicine, Inha University College of Medicine, Incheon, Korea.
  • 4Inha Research Institute for Medical Science, Inha University College of Medicine, Incheon, Korea.
  • 5Department of Internal Medicine, Gachon University College of Medicine, Incheon, Korea.
  • 6Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: Although tetracycline or doxycycline is the drug of choice for the treatment of scrub typhus, they are not recommended for children and pregnant women. Futhermore, the emergence of doxycycline resistant strain of Orientia tustusgamushi has aroused to find new therapeutic drugs. So, this study was aimed to evaluate the clinical efficacy of telithromycin, the first ketolide antibiotic for the treatment of scrub typhus in comparison with doxycycline.
MATERIALS AND METHODS
Mild scrub typhus patients who were admitted to two university hospitals located in Incheon city from October 2004 through November 2004 were enrolled. Patients were assigned to telithromcyin (the first day, oral 800 mg every 12 hours and then 800 mg/day) and doxycycline treatment groups (oral 200 mg/day). Time and days to defevescence were analysed to evaluate the efficacy of the two antibiotics.
RESULTS
Among a total of fifty patients, twenty six (52.0%) patients were excluded. Twenty four (48.0%) enrolled patients, telithromcyin and doxycycline were administered to thirteen (54.2%) and eleven patients (45.8%), respectively. In telithromycin treatment group, one patient (7.6%) was dropped out due to nausea and diarrhea. In doxycycline group, the mean age was higher (P=0.031) but the duration of fever before admission was shorter (P=0.015) than telithromycin group. There was no treatment failure nor relapse in either treatment groups. The mean time to defevescence was 17.7 hours for telithromycin group and 30.7 hours for doxycycline group (P=0.003). Ten patients (83.3%) in telithromycin group and four patients (36.4%) in doxycycline group became afebrile within the first day (P=0.048).
CONCLUSION
Telithromycin has achieved good therapeutic outcome and more rapid response than doxycycline for the treatment of mild to moderate scrup typhus, so it suggests that telithromycin would be an alternative therapeutic agent for scrub typhus.

Keyword

Scrub typhus; Rickettsiosis; Orientia tsutusgamushi; Telithromycin; Ketolide; Doxycycline

MeSH Terms

Anti-Bacterial Agents
Child
Diarrhea
Doxycycline
Female
Fever
Hospitals, University
Humans
Incheon
Nausea
Pregnant Women
Recurrence
Scrub Typhus*
Tetracycline
Treatment Failure
Typhus, Epidemic Louse-Borne
Anti-Bacterial Agents
Doxycycline
Tetracycline
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr